Meloxicam and Monoplegia - a phase IV clinical study of FDA data

Summary:

Monoplegia is reported as a side effect among people who take Meloxicam (meloxicam), especially for people who are female, 60+ old, also take Humira, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Monoplegia when taking Meloxicam. It is created by eHealthMe based on reports of 64,757 people who have side effects when taking Meloxicam from the FDA, and is updated regularly.

What is Meloxicam?

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 68,017 Meloxicam users. Check the latest studies of Meloxicam.

What is Monoplegia?

Monoplegia (a paralysis of a single limb) is found to be associated with 476 drugs and 659 conditions by eHealthMe. Check the latest studies of Monoplegia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

64,757 people reported to have side effects when taking Meloxicam.
Among them, 21 people (0.03%) have Monoplegia.

Among these 21 people:

What is the gender of people who have Monoplegia when taking Meloxicam? *

female: 76.19 %
male: 23.81 %

What is the age of people who have Monoplegia when taking Meloxicam? *

What are other drugs people take besides Meloxicam? *

What are other side effects people have besides Monoplegia? *

Gait Disturbance: 7 people, 33.33%
Loss Of Consciousness: 7 people, 33.33%
Cervical Cord Compression (compression of spinal cord at site of cervical vertebrae): 6 people, 28.57%
Anaemia (lack of blood): 6 people, 28.57%
Spinal Disorder (disease of spine a back bone): 6 people, 28.57%
Head Injury: 6 people, 28.57%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 28.57%
Intervertebral Disc Protrusion (spinal disc protrusion): 6 people, 28.57%
Paresis (a condition of muscular weakness): 6 people, 28.57%
Monoparesis (one limb is very weak, but not completely paralyzed): 6 people, 28.57%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 42.86%
High Blood Pressure: 7 people, 33.33%
Osteoporosis (bones weak and more likely to break): 6 people, 28.57%
Gastric Disorder (disease of stomach): 6 people, 28.57%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 14.29%
Insomnia (sleeplessness): 2 people, 9.52%
Trigeminal Neuralgia (a painful condition of the nerve responsible for most facial sensation): 1 person, 4.76%
Prostate Cancer: 1 person, 4.76%
Neuropathy Peripheral (surface nerve damage): 1 person, 4.76%
Inflammation: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Meloxicam and have Monoplegia?

- Check whether Monoplegia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Meloxicam:

Meloxicam (68,017 reports)

Monoplegia treatments and more:

Monoplegia (5,405 reports)

Browse all side effects of Meloxicam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Monoplegia:

Monoplegia (476 drugs)

Browse all the conditions that are associated with Monoplegia:

Monoplegia (659 conditions)

Related publications that referenced our studies

Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on meloxicam (the active ingredients of Meloxicam) and Meloxicam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.